help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shuto, T.
Right arrow Articles by Koga, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shuto, T.
Right arrow Articles by Koga, T.

Endocrinology, Vol 134, 1121-1126, Copyright © 1994 by Endocrine Society


ARTICLES

Dexamethasone stimulates osteoclast-like cell formation by inhibiting granulocyte-macrophage colony-stimulating factor production in mouse bone marrow cultures

T Shuto, T Kukita, M Hirata, E Jimi and T Koga
Department of Biochemistry, Faculty of Dentistry, Kyushu University, Fukuoka, Japan.

We investigated the effect of glucocorticoid on the generation of osteoclasts. In mouse bone marrow culture systems, dexamethasone, a synthetic glucocorticoid analog, enhanced osteoclast-like cell formation induced by 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] in a dose- dependent manner. Conversely, dexamethasone inhibited the endogenous production of granulocyte-macrophage colony-stimulating factor (GM-CSF) in bone marrow cultures. GM-CSF, when added exogenously, suppressed not only the osteoclast-like cell formation induced by 1,25-(OH)2D3, but also the stimulatory effect of dexamethasone, and addition of anti-GM- CSF neutralizing antibody to the cultures significantly increased the osteoclast-like cell formation induced by 1,25-(OH)2D3. These observations suggest that dexamethasone directly affects bone marrow cells and enhances osteoclast generation by inhibiting the endogenous production of GM-CSF, which may function as a negative regulator of osteoclast formation.


This article has been cited by other articles:


Home page
EndocrinologyHome page
C. Swanson, M. Lorentzon, H. H. Conaway, and U. H. Lerner
Glucocorticoid Regulation of Osteoclast Differentiation and Expression of Receptor Activator of Nuclear Factor-{kappa}B (NF-{kappa}B) Ligand, Osteoprotegerin, and Receptor Activator of NF-{kappa}B in Mouse Calvarial Bones
Endocrinology, July 1, 2006; 147(7): 3613 - 3622.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
I. Take, Y. Kobayashi, Y. Yamamoto, H. Tsuboi, T. Ochi, S. Uematsu, N. Okafuji, S. Kurihara, N. Udagawa, and N. Takahashi
Prostaglandin E2 Strongly Inhibits Human Osteoclast Formation
Endocrinology, December 1, 2005; 146(12): 5204 - 5214.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. J. Oursler, E. W. Bradley, S. L. Elfering, and C. Giulivi
Native, not nitrated, cytochrome c and mitochondria-derived hydrogen peroxide drive osteoclast apoptosis
Am J Physiol Cell Physiol, January 1, 2005; 288(1): C156 - C168.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Takuma, T. Kaneda, T. Sato, S. Ninomiya, M. Kumegawa, and Y. Hakeda
Dexamethasone Enhances Osteoclast Formation Synergistically with Transforming Growth Factor-{beta} by Stimulating the Priming of Osteoclast Progenitors for Differentiation into Osteoclasts
J. Biol. Chem., November 7, 2003; 278(45): 44667 - 44674.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S.-K. Lee, J. F. Kalinowski, S. L. Jastrzebski, L. Puddington, and J. A. Lorenzo
Interleukin-7 Is a Direct Inhibitor of in Vitro Osteoclastogenesis
Endocrinology, August 1, 2003; 144(8): 3524 - 3531.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S.-K. Lee, J. Kalinowski, S. Jastrzebski, and J. A. Lorenzo
1,25 (OH)2 Vitamin D3-Stimulated Osteoclast Formation in Spleen-Osteoblast Cocultures Is Mediated in Part by Enhanced IL-1{alpha} and Receptor Activator of NF-{kappa}B Ligand Production in Osteoblasts
J. Immunol., September 1, 2002; 169(5): 2374 - 2380.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Lethimonier, G. Flouriot, O. Kah, and B. Ducouret
The Glucocorticoid Receptor Represses the Positive Autoregulation of the Trout Estrogen Receptor Gene by Preventing the Enhancer Effect of a C/EBP{beta}-Like Protein
Endocrinology, August 1, 2002; 143(8): 2961 - 2974.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. M. Lean, K. Fuller, and T. J. Chambers
FLT3 ligand can substitute for macrophage colony-stimulating factor in support of osteoclast differentiation and function
Blood, November 1, 2001; 98(9): 2707 - 2713.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. L. Bost, J. L. Bento, J. K. Ellington, I. Marriott, and M. C. Hudson
Induction of Colony-Stimulating Factor Expression following Staphylococcus or Salmonella Interaction with Mouse or Human Osteoblasts
Infect. Immun., September 1, 2000; 68(9): 5075 - 5083.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. Huang, J. Xu, D. J. Wood, and M. H. Zheng
Gene Expression of Osteoprotegerin Ligand, Osteoprotegerin, and Receptor Activator of NF-{kappa}B in Giant Cell Tumor of Bone : Possible Involvement in Tumor Cell-Induced Osteoclast-Like Cell Formation
Am. J. Pathol., March 1, 2000; 156(3): 761 - 767.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. O. Abu, A. Horner, V. Kusec, J. T. Triffitt, and J. E. Compston
The Localization of the Functional Glucocorticoid Receptor {alpha} in Human Bone
J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 883 - 889.
[Abstract] [Full Text]


Home page
J Intensive Care MedHome page
I. R. Reid
Glucocorticoid Osteoporosis: Reid IR Glucocorticoid osteoporosis J Intensive Care Med 1999, 14231-242
J Intensive Care Med, September 1, 1999; 14(5): 231 - 242.
[PDF]


Home page
EndocrinologyHome page
S.-K. Lee and J. A. Lorenzo
Parathyroid Hormone Stimulates TRANCE and Inhibits Osteoprotegerin Messenger Ribonucleic Acid Expression in Murine Bone Marrow Cultures: Correlation with Osteoclast-Like Cell Formation
Endocrinology, August 1, 1999; 140(8): 3552 - 3561.
[Abstract] [Full Text]


Home page
NeuroscientistHome page
C. A. Roca, P. J. Schmidt, and D. R. Rubinow
Review : Gonadal Steroids and Affective Illness
Neuroscientist, July 1, 1999; 5(4): 227 - 237.
[Abstract] [PDF]


Home page
EndocrinologyHome page
K. Matsuzaki, K. Katayama, Y. Takahashi, I. Nakamura, N. Udagawa, T. Tsurukai, R. Nishinakamura, Y. Toyama, Y. Yabe, M. Hori, et al.
Human Osteoclast-Like Cells Are Formed from Peripheral Blood Mononuclear Cells in a Coculture with SaOS-2 Cells Transfected with the Parathyroid Hormone (PTH)/PTH-Related Protein Receptor Gene
Endocrinology, February 1, 1999; 140(2): 925 - 932.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
Y. Y. Myint, K. Miyakawa, M. Naito, L. D Shultz, Y. Oike, K.-i. Yamamura, and K. Takahashi
Granulocyte/Macrophage Colony-Stimulating Factor and Interleukin-3 Correct Osteopetrosis in Mice with Osteopetrosis Mutation
Am. J. Pathol., February 1, 1999; 154(2): 553 - 566.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. R. Reid
Glucocorticoid Effects on Bone
J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1860 - 1862.
[Full Text]


Home page
EndocrinologyHome page
R. M. Uht, C. M. Anderson, P. Webb, and P. J. Kushner
Transcriptional Activities of Estrogen and Glucocorticoid Receptors Are Functionally Integrated at the AP-1 Response Element
Endocrinology, July 1, 1997; 138(7): 2900 - 2908.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
N. Udagawa, N. J. Horwood, J. Elliott, A. Mackay, J. Owens, H. Okamura, M. Kurimoto, T. J. Chambers, T.  J. Martin, and M. T. Gillespie
Interleukin-18 (Interferon-gamma -inducing Factor) Is Produced by Osteoblasts and Acts Via Granulocyte/Macrophage Colony-stimulating Factor and Not Via Interferon-gamma to Inhibit Osteoclast Formation
J. Exp. Med., March 17, 1997; 185(6): 1005 - 1012.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society